Curevo Inc: Clinical Trials

2 trials sponsored by Curevo Inc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Active not recruiting 1

Follow Curevo Inc: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older
Amezosvatein Antigen High Dose Arm A, Amezosvatein Antigen Low Dose Arm B, Shingrix - Herpes Zoster, Shingles
Phase 2Active not recruitingCurevo Inc15162022-02-022025-09-30
Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects
CRV 101, Placebo - Herpes Zoster, Varicella Zoster
Phase 1CompletedCurevo Inc902019-01-032021-02-11

Conditions studied

Herpes Zoster (2)  ·  Chickenpox (1)

Interventions

Sodium Chloride (1)

Countries

United States (2)

Top investigators

Corey Casper, MD (1)  ·  Guy De La Rosa, MD (1)  ·  John E Ervin, MD (1)  ·  Lisa Shelton (1)  ·  Lisa Shelton, ARNP (1)